Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Evira Study: Additional Support During Obesity Treatment
Sponsor: Karolinska Institutet
Summary
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with obesity medication in adolescents with obesity. The main question it aims to answer is: \- Can a combination of a digi-physical treatment tool and obesity medication improve treatment outcomes for patients with obesity compared to patients treated with obesity medications alone? This is a randomized controlled two-arm multicenter study where participants will be randomized to the intervention group (digi-physical treatment+medication) or control group (medication only). Participants will be followed for six months.
Official title: Evaluation of a Digital Treatment Tool in Combination With Obesity Medications
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-02-13
Completion Date
2027-05-01
Last Updated
2026-05-05
Healthy Volunteers
No
Conditions
Interventions
Digi-physical treatment tool, Evira
A digi-physical treatment tool named Evira will be used to provide behavioral treatment.
Obesity medication with liraglutide or semaglutide
Obesity medication with liraglutide or semaglutide according to the clinic's standard procedure
Locations (2)
HKH Crown Princess Victoria's Childrens and youth Hospital Linköping
Linköping, Sweden
Ystad lasarett, Barn och ungdomsmedicinmottagningen
Ystad, Sweden